-
Something wrong with this record ?
Routine use of automated FiO2 control in Poland: prospective registry and survey
M. Wilinska, TE. Bachman, P. Piwowarczyk, M. Kostuch, J. Tousty, K. Berła, R. Hajdar, M. Skrzypek
Status not-indexed Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- Publication type
- Journal Article MeSH
OBJECTIVE: The performance of automated control of inspired oxygen (A-FiO2) has been confirmed in dozens of studies but reports of routine use are limited. Broadly adopted in Poland, our aim is to share that experience. METHODS: We used a prospectively planned observational study of the performance, general use patterns, unit practices, and problems with A-FiO2, based on a web registry of case reports, complemented by surveys of subjective impressions. RESULTS: In 2019, a total of 92 A-FiO2 systems were in routine use in 38 centers. Of the 38 centers, 20 had agreed in 2013 to participate in the project. In these centers, A-FiO2 was applied in infants of all weights, but some centers restricted its use to weaning from oxygen and unstable infants. A cohort had reported their experience with each use (5/20 centers, 593 cases). A quarter of those infants were managed with a lower target range and three-quarters with alarms looser than European guidelines for manual SpO2 control. The perceived primary advantages of A-FiO2 were as follows: keeping the readings in the target range, reducing exposure to SpO2 extremes, reducing risk from nurse distraction, reducing workload, and reducing alarm fatigue. Practices did evolve with experience, including implementing changes in the alarm strategy, indications for use, and target range. The potential for over-reliance on automation was cited as a risk. There were a few reports of limited effectiveness (moderate 12/593 and poor 2/593). CONCLUSIONS: Automated oxygen control is broadly perceived by users as an improvement in controlling SpO2 with infrequent problems.
Clinical Department of Neonatology Independent Public Hospital Warsaw Poland
Department of Neonatology and Intensive Neonatal Care Pomeranian Medical University Szczecin Poland
Department of Neonatology Centre of Postgraduate Medical Education Warsaw Poland
Department of Neonatology Complex of Health Care Facilities Ostrow Wielkopolski Poland
Department of Neonatology Provincial Specialist Hospital Biala Podlaska Poland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015370
- 003
- CZ-PrNML
- 005
- 20231020093540.0
- 007
- ta
- 008
- 231010s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fped.2023.1213310 $2 doi
- 035 __
- $a (PubMed)37719452
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Wilinska, M $u Department of Neonatology, Centre of Postgraduate Medical Education, Warsaw, Poland
- 245 10
- $a Routine use of automated FiO2 control in Poland: prospective registry and survey / $c M. Wilinska, TE. Bachman, P. Piwowarczyk, M. Kostuch, J. Tousty, K. Berła, R. Hajdar, M. Skrzypek
- 520 9_
- $a OBJECTIVE: The performance of automated control of inspired oxygen (A-FiO2) has been confirmed in dozens of studies but reports of routine use are limited. Broadly adopted in Poland, our aim is to share that experience. METHODS: We used a prospectively planned observational study of the performance, general use patterns, unit practices, and problems with A-FiO2, based on a web registry of case reports, complemented by surveys of subjective impressions. RESULTS: In 2019, a total of 92 A-FiO2 systems were in routine use in 38 centers. Of the 38 centers, 20 had agreed in 2013 to participate in the project. In these centers, A-FiO2 was applied in infants of all weights, but some centers restricted its use to weaning from oxygen and unstable infants. A cohort had reported their experience with each use (5/20 centers, 593 cases). A quarter of those infants were managed with a lower target range and three-quarters with alarms looser than European guidelines for manual SpO2 control. The perceived primary advantages of A-FiO2 were as follows: keeping the readings in the target range, reducing exposure to SpO2 extremes, reducing risk from nurse distraction, reducing workload, and reducing alarm fatigue. Practices did evolve with experience, including implementing changes in the alarm strategy, indications for use, and target range. The potential for over-reliance on automation was cited as a risk. There were a few reports of limited effectiveness (moderate 12/593 and poor 2/593). CONCLUSIONS: Automated oxygen control is broadly perceived by users as an improvement in controlling SpO2 with infrequent problems.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bachman, T E $u Department Medical Technology, School of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
- 700 1_
- $a Piwowarczyk, P $u Clinical Department of Neonatology, Independent Public Hospital, Warsaw, Poland
- 700 1_
- $a Kostuch, M $u Department of Neonatology, Centre of Postgraduate Medical Education, Warsaw, Poland
- 700 1_
- $a Tousty, J $u Department of Neonatology and Intensive Neonatal Care, Pomeranian Medical University, Szczecin, Poland
- 700 1_
- $a Berła, K $u Department of Neonatology, Complex of Health Care Facilities, Ostrow Wielkopolski, Poland
- 700 1_
- $a Hajdar, R $u Department of Neonatology, Provincial Specialist Hospital, Biala Podlaska, Poland
- 700 1_
- $a Skrzypek, M $u Department of Biostatistics Medical University of Silesia, School of Health Sciences in Bytom, Bytom, Poland
- 773 0_
- $w MED00194312 $t Frontiers in pediatrics $x 2296-2360 $g Roč. 11, č. - (2023), s. 1213310
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37719452 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093534 $b ABA008
- 999 __
- $a ok $b bmc $g 1997118 $s 1201732
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 11 $c - $d 1213310 $e 20230831 $i 2296-2360 $m Frontiers in pediatrics $n Front Pediatr $x MED00194312
- LZP __
- $a Pubmed-20231010